Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide for high-output enterocutaneous fistula or enterostomy
2013-003998-10Phase 3Completed
- Sponsor
- Academic medical center
- Start
- Oct 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lanreotide in enterocutaneous fistula (ECF) and High output stoma (HOS) (2 arms), sponsored by Academic medical center. Primary endpoint: Number of responders at week 8. Started Oct 2013; status: completed.
02
Drugs
lanreotide
03
Conditions
enterocutaneous fistula (ECF)High output stoma (HOS)
Beyond the preview
Go deeper on 2013-003998-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003998-10.